C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1998
10/20/1998	US5824319 Vaccine for immunization against chicken pox and shingles
10/20/1998	US5824318 Avirulent herpetic viruses useful as tumoricidal agents and vaccines
10/20/1998	US5824316 Deleting the nucleic acid sequence encoding the leader (l) proteinase from an infectious cdna copy of the viral genome
10/20/1998	US5824315 And complexs between them; attaching n-terminus of the peptide epitope a hydrophobic amino acid or peptide containing it; treatment of autoimmune diseases
10/20/1998	US5824309 Peptides inserted into the frame of structural protein
10/20/1998	US5824307 Human-murine chimeric antibodies against respiratory syncytial virus
10/20/1998	US5824306 Dirofilaria and brugia ankyrin proteins, nucleic acid molecules, and uses thereof
10/20/1998	US5824303 Dna sequence encoding, proteins and peptides
10/20/1998	US5824302 Bt=bacillus thuringiensis
10/20/1998	US5824299 Administering an ip-10 polypeptide to decrease non-neoplastic endothelial cell proliferation; treating hemangioma, keloids, proliferative retinal disorder, inflammation, fibrosis
10/20/1998	US5824297 Administering transforming growth factor beta to cancer patients before chemotherapy; side effect reduction of oraland gastrointestinal mucositis
10/20/1998	US5824230 Purifying by depositing a thin layer film of non-crosslinked fibrin polymer onto outer wall coupling with a enzyme, dissolving with an acid buffer, depolymerizing to fibrin coagulants
10/20/1998	CA1340097C Synthetic antigen for detection of aids-related disease
10/20/1998	CA1340096C Analogs of atrial natriuretic peptides
10/20/1998	CA1340091C Enhanced protein production in bacteria by employing novel ribosome binding site
10/18/1998	CA2203084A1 The inositol phosphate pathway and its implication in alzheimer's disease
10/18/1998	CA2203083A1 Gene and cdna involved in alzheimer's disease
10/18/1998	CA2203071A1 Chromosome 10 gene and gene products related to alzheimer's disease
10/18/1998	CA2203070A1 Chromosome 6 gene and gene products related to alzheimer's disease
10/18/1998	CA2203069A1 Chromosome 12 gene and gene products related to alzheimer's disease
10/18/1998	CA2203068A1 Chromosome 1p gene and gene products related to alzheimer's disease
10/15/1998	WO1998045712A2 20 human secreted proteins
10/15/1998	WO1998045467A1 NOVEL TGF-β PATHWAY GENES
10/15/1998	WO1998045465A1 Transgenic, non-human animal with protein deficiency, cells derived therefrom, use of said animal and cells, and method of producing said transgenic animal
10/15/1998	WO1998045464A1 Transgenic, non-human animal with protein deficiency, cells derived therefrom, use of said animal and cells, and method of producing said transgenic animal
10/15/1998	WO1998045461A1 An oleosin 5' regulatory region for the modification of plant seed lipid composition
10/15/1998	WO1998045460A1 A sunflower albumin 5' regulatory region for the modification of plant seed lipid composition
10/15/1998	WO1998045458A1 An engineered seed protein having a higher percentage of essential amino acids
10/15/1998	WO1998045450A1 Purified telomerase
10/15/1998	WO1998045443A1 Radioisotope concentrator methods and compositions
10/15/1998	WO1998045442A2 Secreted f-spondin homologs
10/15/1998	WO1998045441A1 Human gtp binding protein
10/15/1998	WO1998045440A1 Human fatty acid binding protein
10/15/1998	WO1998045439A1 Human tumor-associated membrane protein
10/15/1998	WO1998045438A1 Ucp3: an uncoupling protein homologue
10/15/1998	WO1998045437A2 SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
10/15/1998	WO1998045436A2 SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
10/15/1998	WO1998045435A2 SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
10/15/1998	WO1998045434A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/15/1998	WO1998045433A1 Proteins and compositions for modulating mitosis
10/15/1998	WO1998045432A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998	WO1998045430A1 Immune modulation by polypeptides related to cr1
10/15/1998	WO1998045429A2 Polypeptides involved in the staurosporine induced apoptotic pathway
10/15/1998	WO1998045428A1 Fanconi-gen ii
10/15/1998	WO1998045427A2 Insulin-like growth factor agonist peptides
10/15/1998	WO1998045424A1 Methods and materials for making and using transgenic dicamba-degrading organisms
10/15/1998	WO1998045422A1 Non human transgenic animal in which the expression of the gene coding for insulin is deleted
10/15/1998	WO1998045421A2 Hepatitis b virus mutations
10/15/1998	WO1998045420A1 Pca3, pca3 genes, and methods of use
10/15/1998	WO1998045419A1 Transgenic expression in genital tract and sexual accessory glands
10/15/1998	WO1998045408A2 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/15/1998	WO1998045333A1 Method for production of antibodies to specific sites of rapamycin
10/15/1998	WO1998045329A1 Natriuretic peptide derivatives
10/15/1998	WO1998045328A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998	WO1998045327A1 Peptide fragments of myelin basic protein, their pharmaceutical compositions and their use in treating multiple sclerosis
10/15/1998	WO1998045326A1 Cell zinc finger polynucleotides and splice variant polypeptides encoded thereby
10/15/1998	WO1998045325A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998	WO1998045324A1 Use of cholera toxin mutants as mucosal adjuvants
10/15/1998	WO1998045323A1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
10/15/1998	WO1998045322A2 Diagnosis method and reagents
10/15/1998	WO1998045319A2 COMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION BETWEEN α-CATENIN and β-CATENIN
10/15/1998	WO1998045318A1 Activated peptides and conjugates
10/15/1998	WO1998045314A1 Composition and method for treatment of cmv infections
10/15/1998	WO1998045313A1 Novel uncoupling protein and methods of use
10/15/1998	WO1998045312A1 Serogroup-specific nucleotide sequences in the molecular typing of bacterial isolates and the preparation of vaccines thereto
10/15/1998	WO1998044955A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
10/15/1998	WO1998044954A1 Metal ion transporter and uses therefor
10/15/1998	WO1998044946A1 Viral obesity methods and compositions
10/15/1998	WO1998044945A1 Non-infectious, protease defective hiv particles and nucleic acid molecules encoding therefor
10/15/1998	WO1998044944A2 Stabilized human papillomavirus formulations
10/15/1998	WO1998044943A1 Leishmania vaccine
10/15/1998	WO1998044939A1 Anti-peptide antibody against human cytochrome p450 3a4
10/15/1998	WO1998044938A1 Modified proteins which bind extracellular matrix components
10/15/1998	WO1998044908A1 Method of regulating epithelial growth
10/15/1998	WO1998044803A1 Dna molecule encoding tomato ringspot virus proteins and uses thereof
10/15/1998	WO1998044788A2 Animal model for evaluation of vaccines
10/15/1998	WO1998044787A1 Transgenic non-human animal, tissue, cell cultures, and cells derived therefrom, and use thereof
10/15/1998	WO1998044786A1 Transgenic non-human animal, tissue, cell cultures, and cells derived therefrom, and use thereof
10/15/1998	WO1998044785A1 Transgenic non-human animal, tissue, cell cultures and cells derived therefrom, and use thereof
10/15/1998	WO1998044781A1 Regulatory element for expressing genes in plants
10/15/1998	WO1998035693A3 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
10/15/1998	WO1998030589A3 Secreted proteins and polynucleotides encoding them
10/15/1998	WO1998029433A3 Method for solubilization and naturation of somatotropins
10/15/1998	WO1998025962A3 Secreted proteins and polynucleotides encoding them
10/15/1998	WO1998025957A3 Human prt1-like subunit protein (hprt1) and human eif4g-like protein (p97) genes
10/15/1998	WO1998024807A3 Somatostatin antagonists
10/15/1998	WO1998023747A3 Isolated mammalian dendritic cell genes; related reagents
10/15/1998	WO1998022588A3 An improved method for the production and purification of adenoviral vectors
10/15/1998	WO1998022500A3 Modulation of interactions between myosin and integrins
10/15/1998	WO1998022146A3 Optical diagnostic agents for diagnosis of neurodegenerative diseases by means of near infra-red radiation (nir radiation)
10/15/1998	WO1998018925A3 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
10/15/1998	WO1998017810A3 Multi-functional chimeric hematopoietic receptor agonists
10/15/1998	DE19715149A1 Krebstherapeutikum und Diagnose zur Charakterisierung von Krebszellen mit individueller Eigenschaft Cancer therapy and diagnosis for the characterization of cancer cells with individual property
10/15/1998	CA2287778A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998	CA2287084A1 Diagnosis method and reagents
10/15/1998	CA2286860A1 Radioisotope concentrator methods and compositions
10/15/1998	CA2286390A1 Human tumor-associated membrane protein
10/15/1998	CA2286348A1 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998	CA2286346A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998	CA2286311A1 Method for production of antibodies to specific sites of rapamycin

1 ... 2350 2351 2352 2353 2354 2355 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 ... 2916